Well-being of Caregivers (Caregiver Strain Index)
What this study is
This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
What's being tested
- home care
Intervention · OTHER
This is the interventional arm where patients receive the transplant care in their homes.
Study details
- Official title
- A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
- Sponsor
- Duke University
- Conditions
- Well-being of Caregivers (Caregiver Strain Index)
- Enrolling
- 150 people
- Starts
- 2018-09-28
- Est. completion
- 2027-01-30
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedPatient
You may qualify if
- Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
- Age 18-80 years
- Karnofsky Performance Scale KPS> 80
- Able to read/write English
- A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
You can't join if
- Lack of a caregiver
- Pregnant women
- Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
- Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota
Caregiver
You may qualify if
- Identified by patient as their primary caregiver
- Meet standard clinical criteria for being a caregiver (able to drive and take care of patient)
- Age 18-80 years
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openDuke University Medical Center
Durham, North Carolina, United States
- Anthony Sung, MD · Contact919-668-5710anthony.sung@duke.edu
Recruiting
Study team
Sponsor
Duke University
Study ID Pro00089697
Principal investigator
Anthony Sung, MD
Duke Health
Principal investigator
Nelson Chao, MD
Duke Health
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.